Anavo Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Series 1

  • Latest Deal Amount
  • $30.8M

  • Investors
  • 5

Anavo Therapeutics General Information

Description

Developer of a phosphatase-based drug discovery designed to meet a rich target space previously considered undruggable for decades. The company's platform expertise in phosphatase-driven disease biology and drug discovery, the therapeutic potential of phosphatase-targeted modulators for our first-in-class proprietary pipeline, and partnerships, technology is developing multiple-class therapeutic programs and aims to build on partnerships around its platform to establish a rich pipeline across several indications and attract scientific expertise in phosphatase-driven disease biology and drug discovery, enabling clients with scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators.

Contact Information

Website
www.anavotx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • J.H. Oortweg 19
  • 2333 CH Leiden
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • J.H. Oortweg 19
  • 2333 CH Leiden
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anavo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 02-May-2023 $30.8M Completed Generating Revenue
To view Anavo Therapeutics’s complete valuation and funding history, request access »

Anavo Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a phosphatase-based drug discovery designed to meet a rich target space previously considered undruggable f
Drug Discovery
Leiden, Netherlands
16 As of 2024

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Anavo Therapeutics Competitors (1)

One of Anavo Therapeutics’s competitors is Repertoire Immune Medicines, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Repertoire Immune Medicines Venture Capital-Backed Cambridge, MA
You’re viewing 1 of 1 competitors. Get the full list »

Anavo Therapeutics Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Anavo Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026037930-A1 Amide derivatives as wip1 inhibitors Pending 16-Aug-2024
WO-2026037931-A1 Thiophenecarboxamide derivatives as wip1 inhibitors Pending 16-Aug-2024
WO-2025113806-A1 Thiophene and thiazole derivatives as wip1 inhibitors Inactive 30-Nov-2023 C07D409/12

Anavo Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anavo Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bioqube Ventures Venture Capital Minority
Inkef Venture Capital Minority
MRL Ventures Fund Corporate Venture Capital Minority
M Ventures Corporate Venture Capital Minority
Taiho Ventures Corporate Venture Capital Minority
To view Anavo Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Anavo Therapeutics FAQs

  • When was Anavo Therapeutics founded?

    Anavo Therapeutics was founded in 2020.

  • Where is Anavo Therapeutics headquartered?

    Anavo Therapeutics is headquartered in Leiden, Netherlands.

  • What is the size of Anavo Therapeutics?

    Anavo Therapeutics has 16 total employees.

  • What industry is Anavo Therapeutics in?

    Anavo Therapeutics’s primary industry is Drug Discovery.

  • Is Anavo Therapeutics a private or public company?

    Anavo Therapeutics is a Private company.

  • What is Anavo Therapeutics’s current revenue?

    The current revenue for Anavo Therapeutics is .

  • How much funding has Anavo Therapeutics raised over time?

    Anavo Therapeutics has raised $30.8M.

  • Who are Anavo Therapeutics’s investors?

    Bioqube Ventures, Inkef, MRL Ventures Fund, M Ventures, and Taiho Ventures have invested in Anavo Therapeutics.

  • Who are Anavo Therapeutics’s competitors?

    Repertoire Immune Medicines is a competitor of Anavo Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process